Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Sevim Erdem‐Özdamar
Sign up to set email alerts
154
Publications
2,367
Citation Statements Received
1,959
Citation Statements Given
How they've been cited
3,224
124
2,235
8
How they cite others
2,754
70
1,881
8
Affiliations
Hacettepe University
,
Hacettepe University Hospital
Publications
Order By: Most citations
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
Howard
1
,
Utsugisawa
2
,
Benatar
3
et al.
2017
The Lancet Neurology
868
38
676
4
5
Get access via publisher
Add to collection
Cite
Painful sensory neuropathy
Periquet
1
,
Novak
2
,
Collins
3
et al.
1999
Neurology
Abstract
Show
376
13
282
0
Get access via publisher
Add to collection
Cite
Mutations in a Gene Encoding a Novel SH3/TPR Domain Protein Cause Autosomal Recessive Charcot-Marie-Tooth Type 4C Neuropathy
Senderek
1
,
Bergmann
2
,
Stendel
3
et al.
2003
The American Journal of Human Genetics
Abstract
Show
207
9
195
0
Get access via publisher
Add to collection
Cite
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
Díaz‐Manera
1
,
Kishnani
2
,
Kushlaf
3
et al.
2021
The Lancet Neurology
194
1
152
0
2
Get access via publisher
Add to collection
Cite
Mutations in
GDAP1
Nelis
1
,
Erdem‐Özdamar
2
,
Van den Bergh
3
et al.
2002
Neurology
Abstract
Show
168
13
102
0
Get access via publisher
Add to collection
Cite
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
Mantegazza
1
,
Wolfe
2
,
Muppidi
3
et al.
2021
Neurology
Abstract
Show
84
5
58
1
Get access via publisher
Add to collection
Cite
A novel desmin mutation leading to autosomal recessive limb-girdle muscular dystrophy: distinct histopathological outcomes compared with desminopathies
Çetin
1
,
Balcı-Hayta
2
,
Gündeşli
3
et al.
2013
J Med Genet
Abstract
Show
79
3
50
1
Get access via publisher
Add to collection
Cite
Eculizumab improves fatigue in refractory generalized myasthenia gravis
Andersen
1
,
Mantegazza
2
,
Wang
3
et al.
2019
Qual Life Res
Abstract
Show
61
1
35
0
2
Get access via publisher
Add to collection
Cite
1
2
3
4
5
6